Neoadjuvant Chemotherapy Versus Standard Treatment in Patients With Locally Advanced Colon Cancer
Phase of Trial: Phase III
Latest Information Update: 13 Sep 2019
Price : $35 *
At a glance
- Drugs Capecitabine (Primary) ; Oxaliplatin
- Indications Colon cancer
- Focus Therapeutic Use
- Acronyms NeoCol
- 21 Sep 2018 Planned End Date changed from 1 Aug 2019 to 1 Feb 2025.
- 21 Sep 2018 Planned primary completion date changed from 1 Aug 2018 to 1 Feb 2024.
- 05 Oct 2013 New source identified and integrated (European Clinical Trials Database, EudraCT2013-002363-26).